McConnell suffering ‘occasional lightheadedness’ but is clear to keep working, his doctor says

McConnell suffering ‘occasional lightheadedness’ but is clear to keep working, his doctor says


Top U.S. Senate Republican Mitch McConnell appears to freeze up for more than 30 seconds during a public appearance before he was escorted away, the second such incident in a little more than a month, after an event with the Northern Kentucky Chamber of Commerce in Covington, Kentucky, August 30, 2023 in a still image from video.

ABC Affiliate WCPO | via Reuters

Senate Minority Leader Mitch McConnell is “medically clear” to continue working, the attending physician for the U.S. Congress said one day after the Kentucky Republican froze up during a press conference for the second time this summer.

“Occasional lightheadedness is not uncommon in concussion recovery and can also be expected as a result of dehydration,” said Dr. Brian Monahan in a letter shared Thursday from McConnell’s office.

The doctor was referencing a concussion that McConnell, 81, had suffered in March after a fall at a political fundraiser.

At the start of a Wednesday afternoon press conference in Covington, Kentucky, McConnell abruptly stopped speaking and stared straight ahead for about 30 seconds.

He appeared to fail to respond when an aide approached him to ask if he had heard a reporter’s question. McConnell had been asked for his thoughts about running for reelection.

The episode echoed a similar health scare in July, when McConnell suddenly froze and was briefly unable to speak at a news conference in Washington, D.C.

An aide to McConnell had suggested Wednesday that McConnell’s lapse in Covington was the result of feeling “momentarily lightheaded.”

McConnell participated in a discussion with Rep. Jim Banks, R-Ind., later Wednesday evening, his office confirmed to CNBC.

This is breaking news. Please check back for updates.





Source

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Health

2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit

The ripple is about to become a wave. Right now, there are numerous barriers for people who are considering treating their obesity with GLP-1 drugs. Early on, there were manufacturing bottlenecks that resulted in short supplies of Novo Nordisk ‘s Wegovy and Eli Lilly ‘s Zepbound. There were insurance coverage issues for these pricey treatments, […]

Read More
Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale
Health

Eli Lilly investors shouldn’t sweat rival Novo Nordisk having the first obesity pill on sale

Jim Cramer says don’t sweat Novo Nordisk’s head start over Club holding Eli Lilly in the obesity pill market. Eli Lilly stock slipped about half a percent this morning, while Novo Nordisk shares surged more than 8% after becoming the first to secure FDA approval for a GLP-1 weight-loss pill. “[Novo] got approval ahead of […]

Read More
FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk
Health

FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, on the outskirts of Copenhagen, Denmark, Nov. 24, 2025. Tom Little | Reuters The U.S. Food and Drug Administration on Monday approved the first-ever GLP-1 pill for obesity from Wegovy maker Novo Nordisk, a landmark decision that health experts […]

Read More